Cantitate/Preț
Produs
Total produse
Vezi coșul
Diagnosis and Treatment of Pulmonary Hypertension: From Bench to Bedside de Yoshihiro Fukumoto

Diagnosis and Treatment of Pulmonary Hypertension: From Bench to Bedside

Editat de Yoshihiro Fukumoto
en Limba Engleză Hardback – 13 ian 2017
This book focuses on pulmonary arterial hypertension (PAH, Group 1) and chronic thromboembolic pulmonary hypertension (CTEPH, Group 4) among the various groups of pulmonary hypertension (PH) whose classification was updated into five major categories at the 5th World Symposium held in Nice, France, in 2013. Readers will find recent progress, methods, and up-to-date information on PH mechanisms, diagnostic images, and treatment in the management of PH.
This volume, with contributions by leading researchers worldwide in the field , consists of five parts, starting with the fundamentals of PH, then pathophysiology and genetics, treatment, and right ventricular function.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 76642 lei  39-44 zile
  Springer Nature Singapore – 12 dec 2018 76642 lei  39-44 zile
Hardback (1) 124190 lei  3-5 săpt.
  Springer Nature Singapore – 13 ian 2017 124190 lei  3-5 săpt.

Preț: 124190 lei

Preț vechi: 130726 lei
-5% Nou

Puncte Express: 1863
Preț estimativ în valută:
23768€ • 25074$ • 19807£

Carte disponibilă

Livrare economică 12-26 decembrie

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9789812878397
ISBN-10: 9812878394
Pagini: 200
Ilustrații: VIII, 236 p. 70 illus., 45 illus. in color.
Dimensiuni: 155 x 235 x 17 mm
Greutate: 0.6 kg
Ediția:1st ed. 2017
Editura: Springer Nature Singapore
Colecția Springer
Locul publicării:Singapore, Singapore

Public țintă

Professional/practitioner

Cuprins

Part I Fundamentals of Pulmonary Hypertension.- 1.Clinical Classification.- 2.Diagnosis – Imagings.- Part II Pathophysiology and Genetics.- 3.Pathogenic and Therapeutic Role of MicroRNA in Pulmonary Arterial Hypertension.- 4.Sex Hormones.- 5.Rho-Kinase.- 6.The Unique Property of the Pulmonary Artery Regard-ing the Smooth Muscle Effects of Proteinase-activated Receptor 1 - The Possible Contribution to the Pathogenesis of Pulmonary Hypertension.- 7. Animal Models with Pulmonary Hypertension.- 8.Human Pathology.- 9. Pathophysiology and Genetics: BMPR2.- Part III Treatment of Pulmonary Arterial Hypertension (PAH).- 10. Prostacyclin.- 11. Targeting the NO-sGC-cGMP pathway in pulmonary arterial hypertension.- 12. Endothelin Receptor Antagonist.- 13. LUNG TRANSPLANTATION.- Part IV Treatment of Chronic Thromboembolic Pulmonary Hypertension (CTEPH).- 14. Medical Therapy for Chronic Thromboembolic Pulmonary Hypertension.- 15. Balloon Pulmonary Angioplasty.- 16. Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension.- Part V Right Ventricular Function.- 17. Right Ventricular Function.

Notă biografică

Prof. Yoshihiro Fukumoto Dept. of Internal Medicine, Kurume University School of Medicine

Textul de pe ultima copertă

This book focuses on pulmonary arterial hypertension (PAH, Group 1) and chronic thromboembolic pulmonary hypertension (CTEPH, Group 4) among the various groups of pulmonary hypertension (PH) whose classification was updated into five major categories at the 5th World Symposium held in Nice, France, in 2013. Readers will find recent progress, methods, and up-to-date information on PH mechanisms, diagnostic images, and treatment in the management of PH.
This volume, with contributions by leading researchers worldwide in the field , consists of five parts, starting with the fundamentals of PH, then pathophysiology and genetics, treatment, and right ventricular function.

Caracteristici

Ideal resource to acquire latest info on mechanism, diagnostic images, and treatment in the management of pulmonary hypertension Provides through coverage on treatment for pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) Discusses various topics on pathophysiology and genetics of pulmonary hypertension